Dr. Albert James Mamary, MD

Dr. Mamary practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Mamary's NPI, 1407808033, was assigned on May 16, 2006. Dr. Mamary graduated from Lewis Katz School of Medicine in 1999. Dr. Mamary holds Pennsylvania license MD-418340.

Dr. Mamary's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Mamary's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Mamary is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mamary practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Mamary's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Mamary is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mamary's licenses on file in 2 states: Pennsylvania and New York.

Dmand AI lists acute respiratory failure, asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), hypersomnia, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Mamary treats.

CMS data shows 338 Medicare services from Dr. Mamary across 7 procedure codes in 2024, for 181 Medicare patients. Medicare paid $31,767 for them.

CMS counts 181 Medicare patients who saw Dr. Mamary in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mamary's median patient age at 67, with 49% women.

In 2024, Dr. Mamary wrote 2,679 Medicare Part D claims for 198 patients. 70% of them were for generic drugs. CMS names the drug for 2,347 of them, across 60 drugs with 11 or more claims each, at $2,143,943 in total drug cost. In 2023, CMS named 2,328 claims across 66 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Mamary for performance year 2024, reported as part of a group.

Dmand AI links 24 papers to Dr. Mamary, published from 2010 to 2023. 2020 was the busiest year, with 5. The most frequent topics are Lung Transplantation, Lung and Hypertension, Pulmonary. Dr. Mamary has published most often in Respir Med. Dr. Mamary's most frequent co-authors are Gerard Criner, MD, Francis C. Cordova, MD and Nathaniel T. Marchetti, DO.

Dmand AI links Dr. Mamary to 2 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Bronchiolitis Obliterans Syndrome, Pulmonary Arterial Hypertension and Hypertension, Pulmonary.

CMS Open Payments shows 29 general payments to Dr. Mamary from 6 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $9,097.

Dr. Mamary graduated from Lewis Katz School of Medicine in 1999.

Dr. Mamary is in network with 21 carriers, including Aetna, Elevance and Highmark. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.